Assessment in Work Productivity and the Relationship With Cognitive Symptoms in Patients With MDD Taking Vortioxetine
- First Posted Date
- 2015-01-07
- Last Posted Date
- 2018-01-30
- Lead Sponsor
- Lundbeck Canada Inc.
- Target Recruit Count
- 226
- Registration Number
- NCT02332954
- Locations
- 🇨🇦
CA029, Quebec, Canada
🇨🇦CA013, Chatham, Ontario, Canada
🇨🇦CA003, Mississauga, Ontario, Canada
Real Life Assessment of Abilify Maintena
Terminated
- Conditions
- Schizophrenia
- First Posted Date
- 2014-05-06
- Last Posted Date
- 2017-03-10
- Lead Sponsor
- Lundbeck Canada Inc.
- Target Recruit Count
- 200
- Registration Number
- NCT02131415
- Locations
- 🇨🇦
CA008, Penticton, British Columbia, Canada
🇨🇦CA017, Vancouver, British Columbia, Canada
🇨🇦CA006, Halifax, Nova Scotia, Canada
Bendamustine Hydrochloride (HCl) in Indolent Non-Hodgkin's Lymphoma That Has Progressed During or Following Treatment With a Rituximab Regimen or Previously Untreated Chronic Lymphocytic Leukemia
Phase 3
Completed
- Conditions
- Indolent Non-Hodgkin's LymphomaChronic Lymphocytic Leukemia
- Interventions
- First Posted Date
- 2011-12-26
- Last Posted Date
- 2017-08-14
- Lead Sponsor
- Lundbeck Canada Inc.
- Target Recruit Count
- 90
- Registration Number
- NCT01500083
- Locations
- 🇨🇦
CA016, Kelowna, British Columbia, Canada
🇨🇦CA014, Edmonton, Alberta, Canada
🇨🇦CA015, Calgary, Alberta, Canada
© Copyright 2025. All Rights Reserved by MedPath